PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 158 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $45,000 | -31.8% | 18,913 | -18.8% | 0.00% | – |
| Q2 2022 | $66,000 | -7.0% | 23,284 | 0.0% | 0.00% | – |
| Q1 2022 | $71,000 | 0.0% | 23,284 | 0.0% | 0.00% | – |
| Q4 2021 | $71,000 | -56.4% | 23,284 | 0.0% | 0.00% | – |
| Q3 2021 | $163,000 | -23.5% | 23,284 | +17.8% | 0.00% | – |
| Q3 2019 | $213,000 | -90.5% | 19,774 | -48.0% | 0.00% | -100.0% |
| Q2 2018 | $2,249,000 | +837.1% | 38,018 | +1464.5% | 0.00% | – |
| Q4 2017 | $240,000 | +0.8% | 2,430 | +22.4% | 0.00% | – |
| Q3 2017 | $238,000 | -85.8% | 1,985 | -89.6% | 0.00% | -100.0% |
| Q2 2017 | $1,676,000 | +270.8% | 19,163 | +219.5% | 0.00% | +200.0% |
| Q3 2015 | $452,000 | -47.7% | 5,997 | -19.0% | 0.00% | -50.0% |
| Q2 2015 | $865,000 | – | 7,405 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 200,000 | $20,706,000 | 6.01% |
| Redmile Group, LLC | 230,673 | $23,882,000 | 2.95% |
| WEATHERBIE CAPITAL, LLC | 241,419 | $24,994,000 | 2.31% |
| Tekla Capital Management LLC | 185,820 | $19,238,000 | 2.02% |
| Ghost Tree Capital, LLC | 25,000 | $2,588,000 | 1.59% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $588,741,000 | 1.56% |
| Iguana Healthcare Management, LLC | 25,000 | $2,588,000 | 1.48% |
| Eventide Asset Management | 42,100 | $4,359,000 | 1.34% |
| Bain Capital Public Equity Management, LLC | 401,330 | $41,550,000 | 1.17% |
| Rock Springs Capital Management LP | 31,500 | $3,261,000 | 1.16% |